These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37002192)

  • 21. Characteristics of VCP mutation-associated cardiomyopathy.
    Wang SC; Smith CD; Lombardo DM; Kimonis V
    Neuromuscul Disord; 2021 Aug; 31(8):701-705. PubMed ID: 34244020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathological consequences of VCP mutations on human striated muscle.
    Hübbers CU; Clemen CS; Kesper K; Böddrich A; Hofmann A; Kämäräinen O; Tolksdorf K; Stumpf M; Reichelt J; Roth U; Krause S; Watts G; Kimonis V; Wattjes MP; Reimann J; Thal DR; Biermann K; Evert BO; Lochmüller H; Wanker EE; Schoser BG; Noegel AA; Schröder R
    Brain; 2007 Feb; 130(Pt 2):381-93. PubMed ID: 16984901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased Neurofilament Light Chain and YKL-40 CSF Levels in One Japanese IBMPFD Patient With VCP R155C Mutation: A Clinical Case Report With CSF Biomarker Analyses.
    Ikeda M; Kuwabara T; Takai E; Kasahara H; Furuta M; Sekine A; Makioka K; Yamazaki T; Fujita Y; Nagashima K; Higuchi T; Tsushima Y; Ikeda Y
    Front Neurol; 2020; 11():757. PubMed ID: 32849216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease.
    Ju JS; Fuentealba RA; Miller SE; Jackson E; Piwnica-Worms D; Baloh RH; Weihl CC
    J Cell Biol; 2009 Dec; 187(6):875-88. PubMed ID: 20008565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genotype-phenotype study in patients with valosin-containing protein mutations associated with multisystem proteinopathy.
    Al-Obeidi E; Al-Tahan S; Surampalli A; Goyal N; Wang AK; Hermann A; Omizo M; Smith C; Mozaffar T; Kimonis V
    Clin Genet; 2018 Jan; 93(1):119-125. PubMed ID: 28692196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. mTOR dysfunction contributes to vacuolar pathology and weakness in valosin-containing protein associated inclusion body myopathy.
    Ching JK; Elizabeth SV; Ju JS; Lusk C; Pittman SK; Weihl CC
    Hum Mol Genet; 2013 Mar; 22(6):1167-79. PubMed ID: 23250913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VCP/p97 inhibitor CB-5083 modulates muscle pathology in a mouse model of VCP inclusion body myopathy.
    Cheng C; Weiss L; Leinonen H; Shmara A; Yin HZ; Ton T; Do A; Lee J; Ta L; Mohanty E; Vargas J; Weiss J; Palczewski K; Kimonis V
    J Transl Med; 2022 Jan; 20(1):21. PubMed ID: 34998409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VCP maintains lysosomal homeostasis and TFEB activity in differentiated skeletal muscle.
    Arhzaouy K; Papadopoulos C; Schulze N; Pittman SK; Meyer H; Weihl CC
    Autophagy; 2019 Jun; 15(6):1082-1099. PubMed ID: 30654731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear localization of valosin-containing protein in normal muscle and muscle affected by inclusion-body myositis.
    Greenberg SA; Watts GD; Kimonis VE; Amato AA; Pinkus JL
    Muscle Nerve; 2007 Oct; 36(4):447-54. PubMed ID: 17626287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The multifaceted clinical presentation of VCP-proteinopathy in a Greek family.
    Papadimas GK; Paraskevas GP; Zambelis T; Karagiaouris C; Bourbouli M; Bougea A; Walter MC; Schumacher NU; Krause S; Kapaki E
    Acta Myol; 2017 Dec; 36(4):203-206. PubMed ID: 29770363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myogenic differentiation of VCP disease-induced pluripotent stem cells: A novel platform for drug discovery.
    Llewellyn KJ; Nalbandian A; Weiss LN; Chang I; Yu H; Khatib B; Tan B; Scarfone V; Kimonis VE
    PLoS One; 2017; 12(6):e0176919. PubMed ID: 28575052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapamycin and chloroquine: the in vitro and in vivo effects of autophagy-modifying drugs show promising results in valosin containing protein multisystem proteinopathy.
    Nalbandian A; Llewellyn KJ; Nguyen C; Yazdi PG; Kimonis VE
    PLoS One; 2015; 10(4):e0122888. PubMed ID: 25884947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotypic diversity in an international Cure VCP Disease registry.
    Ikenaga C; Findlay AR; Seiffert M; Peck A; Peck N; Johnson NE; Statland JM; Weihl CC
    Orphanet J Rare Dis; 2020 Sep; 15(1):267. PubMed ID: 32993728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone.
    Custer SK; Neumann M; Lu H; Wright AC; Taylor JP
    Hum Mol Genet; 2010 May; 19(9):1741-55. PubMed ID: 20147319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac-Restricted Expression of VCP/TER94 RNAi or Disease Alleles Perturbs
    Viswanathan MC; Blice-Baum AC; Sang TK; Cammarato A
    J Cardiovasc Dev Dis; 2016 Jun; 3(2):. PubMed ID: 27500162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and muscle imaging findings in 14 mainland chinese patients with oculopharyngodistal myopathy.
    Zhao J; Liu J; Xiao J; Du J; Que C; Shi X; Liang W; Sun W; Zhang W; Lv H; Yuan Y; Wang Z
    PLoS One; 2015; 10(6):e0128629. PubMed ID: 26039504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice.
    Weihl CC; Miller SE; Hanson PI; Pestronk A
    Hum Mol Genet; 2007 Apr; 16(8):919-28. PubMed ID: 17329348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutral lipid storage disease with myopathy in China: a large multicentric cohort study.
    Zhang W; Wen B; Lu J; Zhao Y; Hong D; Zhao Z; Zhang C; Luo Y; Qi X; Zhang Y; Song X; Zhao Y; Zhao C; Hu J; Yang H; Wang Z; Yan C; Yuan Y
    Orphanet J Rare Dis; 2019 Oct; 14(1):234. PubMed ID: 31655616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Valosin-containing protein Asp395Gly mutation in a patient with frontotemporal dementia: a case report.
    Kobayashi R; Naruse H; Kawakatsu S; Iseki C; Suzuki Y; Koyama S; Morioka D; Ishiura H; Mitsui J; Ohta Y; Tsuji S; Toda T; Otani K
    BMC Neurol; 2022 Nov; 22(1):406. PubMed ID: 36329418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of inclusion body myopathy with Paget's disease of bone and frontotemporal dementia (IBMPFD) showing clinical features of motor neuron disease].
    Igari R; Wada M; Sato H; K Hayashi Y; Nishino I; Kato T
    Rinsho Shinkeigaku; 2013; 53(6):458-64. PubMed ID: 23782824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.